These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15465078)

  • 41. Timing and modality of neuroimaging in acute stroke: an Irish perspective.
    McEvoy S; Trainor S; Caffrey N; Torreggiani WC; Collins DR
    Ir Med J; 2009 Apr; 102(4):127. PubMed ID: 19552300
    [No Abstract]   [Full Text] [Related]  

  • 42. [Interventionel MRT: current inventory and preview].
    Wacker FK
    Rofo; 2004 Jul; 176(7):941-3. PubMed ID: 15237334
    [No Abstract]   [Full Text] [Related]  

  • 43. Seeking the "holy grail" of biomarkers to improve stroke risk prediction of clinical scores.
    Williams SR; Lorenzano S
    Neurology; 2016 Sep; 87(12):1194-5. PubMed ID: 27558369
    [No Abstract]   [Full Text] [Related]  

  • 44. Optimizing Blood Pressure Components for a Healthy Brain: The Holy Grail in Blood Pressure Management.
    Fernández-Jiménez R; Real C
    J Am Coll Cardiol; 2022 Apr; 79(14):1336-1339. PubMed ID: 35393013
    [No Abstract]   [Full Text] [Related]  

  • 45. Weight loss pill praised as "holy grail" is withdrawn from US market over cancer link.
    Mahase E
    BMJ; 2020 Feb; 368():m705. PubMed ID: 32079611
    [No Abstract]   [Full Text] [Related]  

  • 46. Multiparametric magnetic resonance imaging of brain disorders.
    Wu O; Dijkhuizen RM; Sorensen AG
    Top Magn Reson Imaging; 2010 Apr; 21(2):129-38. PubMed ID: 21613877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
    J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?
    Alexandrov AV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):342-3. PubMed ID: 16265558
    [No Abstract]   [Full Text] [Related]  

  • 49. Use of MRI in the identification and treatment of early ischemic stroke lesions.
    O'Rourke F; Akhtar N; Emery D; Shuaib A
    CMAJ; 2004 Feb; 170(3):335-6. PubMed ID: 14757667
    [No Abstract]   [Full Text] [Related]  

  • 50. Thrombolysis in patients with stroke and marked clinical fluctuations.
    Calleja S; Rodríguez S; Lahoz CH
    Arch Neurol; 2009 Mar; 66(3):416-8. PubMed ID: 19273766
    [No Abstract]   [Full Text] [Related]  

  • 51. Optimizing an individual's treatment in acute stroke: is a magnetic resonance map leading us towards the holy grail?
    Levine SR
    J Neurol Sci; 2004 Oct; 225(1-2):1-2. PubMed ID: 15465078
    [No Abstract]   [Full Text] [Related]  

  • 52. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].
    Kakuda W; Abo M
    Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The evolving role of acute stroke imaging in intravenous thrombolytic therapy: patient selection and outcomes assessment.
    Sims J; Schwamm LH
    Neuroimaging Clin N Am; 2005 May; 15(2):421-40, xii. PubMed ID: 16198950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultrafast magnetic resonance imaging protocols in stroke.
    Graves MJ; U-King-Im J; Howarth S; Gillard JH
    Expert Rev Neurother; 2006 Jun; 6(6):921-30. PubMed ID: 16784414
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.